We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Foghorn

News List

Lilly and Foghorn enter partnership to develop new cancer medicines Pharmaceutical-Technology
December 15, 2021
Eli Lilly and Company’s research and development group Loxo Oncology at Lilly and Foghorn Therapeutics have entered a strategic partnership to develop new cancer therapies.
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform AmericanPharmaceuticalReview
December 14, 2021
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company and Foghorn Therapeutics Inc. announced a strategic collaboration to create novel oncology medicines by applying Foghorn's proprietary Gene Traffic Control® platform...
Flagship Pioneering Launches Foghorn Therapeutics With Initial Capital Commitment of $50 Million biospace
March 15, 2018
Flagship Pioneering, a unique life science innovation enterprise, today unveiled Foghorn Therapeutics.